USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
30.29
-0.06 (-0.20%)
Jul 21, 2025, 4:00 PM - Market closed

Company Description

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration.

It also provides Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online.

The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau.

USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

USANA Health Sciences, Inc.
USANA Health Sciences logo
CountryUnited States
Founded1992
IPO DateJul 25, 1996
IndustryPackaged Foods
SectorConsumer Staples
Employees1,700
CEOJim Brown

Contact Details

Address:
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
United States
Phone801 954 7100
Websiteusana.com

Stock Details

Ticker SymbolUSNA
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000896264
CUSIP Number90328M107
ISIN NumberUS90328M1071
Employer ID87-0500306
SIC Code2833

Key Executives

NamePosition
Jim BrownChief Executive Officer and President
G. Douglas HekkingChief Financial Officer
Walter NootChief Operating Officer
P. Joshua Foukas J.D.Chief Legal Officer, General Counsel and Corporate Secretary
Brent L. NeidigChief Commercial Officer
Dr. Myron W. Wentz Ph.D.Founder and Chairman Emeritus
Dr. John CuomoExecutive Director of Product Development and Technology
Peter BenedictChief Information Officer
Patrique RichardsExecutive Director of Investor Relations and Business Development
David MulhamChief Sales Officer

Latest SEC Filings

DateTypeTitle
Jul 1, 20258-KCurrent Report
Jun 20, 202511-KAnnual report of employee stock purchase, savings and similar plans
May 27, 2025144Filing
May 21, 2025S-8Securities to be offered to employees in employee benefit plans
May 20, 20258-KCurrent Report
May 9, 2025144Filing
May 6, 202510-QQuarterly Report
May 1, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2025SCHEDULE 13G/AFiling
Apr 22, 20258-KCurrent Report